Fluvoxamine, melatonin and COVID-19

被引:0
|
作者
George M. Anderson
机构
[1] Yale University School of Medicine,Child Study Center and the Department of Laboratory Medicine
来源
Psychopharmacology | 2021年 / 238卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:611 / 611
相关论文
共 50 条
  • [31] Therapeutic Benefits of Melatonin Against COVID-19
    Mubashshir, Muhammad
    Ahmad, Nabeel
    Negi, Tripti
    Rawal, Renu
    Singhvi, Nirjara
    Khatoon, Hina
    Laxmi, Vijya
    Dubey, Om
    Sharma, Renu Bala
    Negi, Ganga
    Ovais, Mohd
    [J]. NEUROIMMUNOMODULATION, 2023, 30 (01) : 196 - 205
  • [32] COVID-19: Melatonin as a potential adjuvant treatment
    Salles, Cristina
    [J]. LIFE SCIENCES, 2020, 253
  • [33] COVID-19: Melatonin as a potential adjuvant treatment
    Zhang, Rui
    Wang, Xuebin
    Ni, Leng
    Di, Xiao
    Ma, Baitao
    Niu, Shuai
    Liu, Changwei
    Reiter, Russel J.
    [J]. LIFE SCIENCES, 2020, 250
  • [34] Sleep, Dietary Melatonin Supplementation, and COVID-19
    Gasmi, Amin
    Semenova, Yuliya
    Noor, Sadaf
    Benahmed, Asma Gasmi
    Bjorklund, Geir
    [J]. CURRENT MEDICINAL CHEMISTRY, 2024, 31 (11) : 1298 - 1314
  • [35] Reply to 'Delirium, sleep, COVID-19 and melatonin'
    D'Agostino, Armando
    Zambrelli, Elena
    [J]. SLEEP MEDICINE, 2020, 75 : 543 - 543
  • [36] Possible role of tryptophan and melatonin in COVID-19
    Essa, Musthafa Mohamed
    Hamdan, Hamdan
    Chidambaram, Saravana Babu
    Al-Balushi, Buthainah
    Guillemin, Gilles J.
    Ojcius, David M.
    Qoronfleh, M. Walid
    [J]. INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2020, 13
  • [37] Why we should not recommend or offer fluvoxamine to COVID-19 patients?
    Trkulja, Vladimir
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (02) : 321 - 322
  • [38] Why we should not recommend or offer fluvoxamine to COVID-19 patients?
    Vladimir Trkulja
    [J]. European Journal of Clinical Pharmacology, 2023, 79 : 321 - 322
  • [39] Fluvoxamine for Acute COVID-19 Infection: Weak Hypothesis, Predictable Failure
    Manu, Peter
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (03) : E342 - E343
  • [40] Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19
    Zeng, Guangting
    Li, Jianqiang
    Wang, Linlin
    Zhang, Zanling
    [J]. MOLECULAR PSYCHIATRY, 2024,